Diagnostics-World
Twitter   LinkedIn Facebookinstagram RSS  
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • Post a Press Release
    • View Press Releases
    • Submit a Story
    • Reprint Articles
  • Advertise
    • Media Kit
    • Digital Advertising Opportunities
    • Lead Generation
    • Whitepapers
    • Webinars
    • Podcasts
    • Editorial Calendar
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside Ebooks
  • Events
    • Webinars
    • Industry Events
    • Dx Conferences
    • Dx World Summit
  • About
    • Editorial Profile
    • Editorial Calendar
    • Contact
  • Dx World Summit
 
  • Cell-Free Antibody Test, Ultrasounds Show Cardiac Impact, Acuity Score Predicts Outcomes: COVID-19 Updates

    Diagnostics World News I Organs-on-Chips technology to evaluate potential vaccines, COVID-19 associated strokes, recovered patients may be asymptomatic carriers, metabolites identified as biomarkers, frontal lobe involvement in abnormal EEGs, and antibodies detectable for several months. Plus: AI-based algorithm predicts acute kidney injury, PerkinElmer screens for COVID-19 and flu in single test, faster more efficient antibody test by U-M scientists, and NYC outbreak linked to European strains of the virus.

    Oct 30, 2020
  • Follow the Money: New Diagnostics for Blood Infection, Dementia, Bone Disease

    Diagnostics World News | Australian company nets cash for finger-prick blood infection diagnostic, AI-powered, “semi-autonomous” bone image diagnostics platform, NIH grants for non-Alzheimer’s dementias, and more.

    Oct 28, 2020
  • ‘Danger Molecule’ Associated With Inflammation, Obesity And Subclinical Cardiovascular Risk—And May Correlate With COVID-19

    Diagnostics World News | It has been known for several years now that a “danger molecule” shows up in the blood when cells in the body are under stress or tissues are injured, inducing a potent inflammatory response—at least in rats. High Mobility Group Box-1 (HMGB1) is in fact one of the best characterized damage-associated molecular patterns.

    Oct 26, 2020
  • «
  • 121
  • 122
  • 123 (current)
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Twitter Icon LinkedIn Icon Facebook Icon

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy